Home›Companies›Industrial & Robotics›Base Molecular Resonance Technologies

Base Molecular Resonance Technologies Holding LLC

Develops material and biological threat detection technology for security and healthcare applications.

Updated Nov 20, 2026·Latest SEC filing Mar 6, 2024·Suggest an edit

About Base Molecular Resonance Technologies

Base Molecular Resonance Technologies is a private company based in Stuart, Florida, incorporated in 2023 in Florida. It has reported $3,057,500 raised in one offering on Form D since December 2023. Its chief executive is Robert Short.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Nov 17, 2023Dec 5, 2023amended Mar 6, 2024$3,057,500of $5.0M target68$44,963EquityRule 506(b)Form D/A ↗1 earlier filing

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Base Molecular Resonance Technologies's Form D filed Mar 6, 2024.

DD
Derek Duke
Executive officer
On every Form D that Base Molecular Resonance Technologies has filed: 2 filings, from Dec 5, 2023 to Mar 6, 2024.
Robert Short
Robert Short
Co-Founder & CEO
On every Form D that Base Molecular Resonance Technologies has filed: 2 filings, from Dec 5, 2023 to Mar 6, 2024.

Sources

  1. SECBase Molecular Resonance Technologies Holding LLC Form D, filed Dec 5, 2023
  2. SECBase Molecular Resonance Technologies Holding LLC filing history
  3. CompanyContact Us
  4. CompanyAbout Us
  5. PressBMRT detection technology announcement
  6. CompanyLeadership